Literature DB >> 15306606

Is symptom control the correct end point for proton pump inhibitor treatment in Barrett's oesophagus?

A I Sarela, C S Verbeke, C Pring, P J Guillou.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15306606      PMCID： PMC1774176          DOI： 10.1136/gut.2004.039867

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.

Authors:  A Giménez; A Minguela; L M de Haro; P Parrilla; J Bermejo; D Pérez; A M García; M A Ortiz; J Molina; R Alvarez
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

2.  Proliferative activity in Barrett's esophagus before and after antireflux surgery.

Authors:  L Q Chen; C Y Hu; L Gaboury; M Pera; P Ferraro; A C Duranceau
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

3.  Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.

Authors:  K Bani-Hani; I G Martin; L J Hardie; N Mapstone; J A Briggs; D Forman; C P Wild
Journal:  J Natl Cancer Inst       Date:  2000-08-16       Impact factor: 13.506

4.  Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.

Authors:  H J Stein; W K Kauer; H Feussner; J R Siewert
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

5.  Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy.

Authors:  Abeezar I Sarela; David G Hick; Caroline S Verbeke; John F Casey; Pierre J Guillou; Geoffrey W B Clark
Journal:  Arch Surg       Date:  2004-05

6.  Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma.

Authors:  A I Sarela; C S Verbeke; J Ramsdale; C L Davies; A F Markham; P J Guillou
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640
  6 in total
  3 in total

1.  Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?

Authors:  Evanthia Zampeli; George Karamanolis; George Morfopoulos; Elias Xirouchakis; Vasiliki Kalampoki; Spyros Michopoulos; Sotiria Savva; Vasilios Tzias; Irene Zouboulis-Vafiadis; Dimitrios Kamberoglou; Spiros D Ladas
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Outcome of surgical fundoplication for extra-oesophageal symptoms of reflux.

Authors:  Mohd Iqbal; A J Batch; Krishna Moorthy; B T Cooper; R T Spychal
Journal:  Surg Endosc       Date:  2008-03-26       Impact factor: 4.584

3.  Barrett's oesophagus: Is there a need for laparoscopic anti-reflux surgery?

Authors:  Abeezar I Sarela
Journal:  J Minim Access Surg       Date:  2005-03       Impact factor: 1.407
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.